Ming Kyler Lei - Chief Financial Officer at NovaBridge Biosciences

Insider Transactions and Holdings

Entity Type: Individual
Role: Chief Financial Officer
Issuer Symbol: NBP on Nasdaq
All Insider Reports: All Insider Reports

There are no Buy or Sell transactions made by Ming Kyler Lei since 18 Apr 2025

There are no transactions reported by Ming Kyler Lei for NovaBridge Biosciences

PortfolioSavvy

See clear takeaways from ownership and insider filings, then verify every insight against the original SEC source.

Built for cautious research use. Research pages are not investment advice, and sponsored placements stay low-density and clearly labeled.

Source: SEC filing records

Coverage includes Forms 13F, 13D/G, 3/4/5, and company facts.

Open SEC Evidence

Trust & policies

About Methodology How We Use SEC Filings Privacy Terms Advertising Disclosure Contact Cookie Settings

Research hubs

Sign Up To Save Research Sign In To Continue Follow New 13F Filings Track Insider Filings Review 13D/G Ownership Company 10-Q/10-K Updates Financial Insights Metric Guides Latest Investment Quarters

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .